衰弱与新诊断类风湿关节炎患者新发癌症的关联
基于2008至2022年Merative MarketScan数据库,纳入73,240例新诊断类风湿关节炎(RA)患者,其中4.1%被判定为衰弱。衰弱患者新发癌症发生率更高且诊断时间更短,但校正人口学、合并症及医疗利用后,衰弱并非癌症风险的独立预测因素。
要点
- 新诊断RA中衰弱者癌症发生更早(中位312天 vs 561天)。
- 衰弱与癌症风险的未校正HR为1.5(95%CI 1.3-1.8)。
- 校正混杂因素后HR降至1.1(95%CI 0.9-1.4),无独立关联。
核心结论
- 在新诊断RA患者中,衰弱单独不是癌症风险增加的独立预测因素。
研究设计与样本
- 回顾性队列研究,使用Merative MarketScan数据库2008至2022年数据,通过诊断代码和药房记录识别新诊断RA患者,基于索赔的衰弱指数分为衰弱与非衰弱组,采用Cox比例风险模型分析。
主要发现
- 73,240例新诊断RA患者中4.1%为衰弱,衰弱组癌症发生率1.5%高于非衰弱组1.3%,中位诊断时间312天短于561天。
- 衰弱与癌症风险的未校正HR为1.5(95%CI 1.3-1.8)。
关键数值与推荐
- 衰弱组与非衰弱组癌症发生率分别为1.5%与1.3%,中位诊断时间分别为312天与561天。
- 未校正HR 1.5(95%CI 1.3-1.8);校正人口学、Charlson合并症指数和医疗利用后HR 1.1(95%CI 0.9-1.4)。
临床怎么用
- 对具有衰弱的RA患者应关注癌症监测,但衰弱本身不构成独立风险分层依据。
- 癌症风险升高可能更多归因于合并症和医疗利用等混杂因素。
局限性
- 研究基于行政索赔数据,衰弱和癌症识别依赖编码算法,可能存在误分类。
- 人群相对年轻,结论外推至老年RA患者需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rheumatoid Arthritis (RA) is associated with an increased risk of cancer, but the underlying risk factors remain poorly understood. Frailty is linked to an increased cancer risk in the general population and is more common among those with RA than those without it. We aimed to evaluate frailty as a risk factor for incident cancer in RA. METHODS: We used the Merative MarketScan databases from 2008 to 2022 to identify individuals with newly diagnosed RA using diagnosis codes and pharmacy records. Patients were categorized as frail or non-frail based on a claims-based frailty index. Incident cancer was identified using a validated algorithm in administrative claims data. Unadjusted and adjusted (for demographics, Charlson comorbidity index, and healthcare utilization) Cox proportional hazards models were created to obtain hazard ratios (HRs) and 95% confidence intervals (95% CIs). RESULTS: Among 73,240 individuals with newly diagnosed RA, 4.1% were classified as frail. Incident cancer occurred more frequently and earlier among frail individuals (1.5% vs. 1.3%; median time to diagnosis: 312 vs. 561 days). Although frailty was associated with higher unadjusted cancer incidence (HR 1.5, 95% CI: 1.3-1.8), this association was attenuated after adjustment (HR 1.1, 95% CI: 0.9-1.4). CONCLUSIONS AND RELEVANCE: Frail patients with newly diagnosed RA had a higher unadjusted incidence of cancer, and shorter time to cancer diagnosis compared to non-frail patients. However, after adjusting for demographics, comorbidities and healthcare utilization, frailty alone was not an independent predictor of increased cancer risk in this relatively younger population with RA.
引用
- Bansal B, Gold LS, Wysham KD, et al. Association between frailty and incident cancer in newly diagnosed patients with rheumatoid arthritis. Semin Arthritis Rheum. 2026. PMID: 41812318. doi:10.1016/j.semarthrit.2026.152965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。